Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil
ACTIVE_NOT_RECRUITING
Status
Conditions
- Primary Pulmonary Hypertension
Interventions
- DRUG: LIQ861 Inhaled Treprostinil
Sponsor
Liquidia Technologies, Inc.
Collaborators